Skip to main content
Retour
Watch Compare

FRACTYL HEALTH, INC.

Qualité des données : 83%
GUTS
NASDAQ Manufacturing Measuring & Analyzing Instruments
0,46 €
▼ 0,01 € (-2,09%)
Cap. Boursière: 72,50 M
Prix
0,46 €
Cap. Boursière
72,50 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -90,89 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-112,67%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio4,27
Interest CoverageN/A

Valorisation

PE (TTM|NTM)
-0,51 | -0,81
Au-dessus de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -0,5 -1,5
P/B — 1,6
ROE % — -54,0
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

5 analystes
Buy
Actuel
0,46 €
+1039.1%
Objectif
5,24 €
2,00 €
6,20 €
8,00 €
Prévisions
P/E Prévisionnel -0,81
BPA Prévisionnel -0,57 €
CA Est. 29,77 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -0,57 €
-0,81 € – -0,38 €
 29,77 M 5
FY2026 -0,65 €
-0,80 € – -0,58 €
 0,0 5

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,18 € -0,07 € +61,1%
Q32025 -0,32 € -0,71 € -124,7%
Q22025 -0,36 € -0,57 € -58,3%
Q12025 -0,50 € -0,49 € +2,0%

ETFs Holding This Stock

BRSIX BRSIX
0,08% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -140,95 M
ROE N/A ROA -159,92%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -90,89 M
ROIC -112,67% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,27
Interest Coverage N/A Asset Turnover N/A
Working Capital 61,02 M Tangible Book Value -3,18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,51 Forward P/E -0,81
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 2,44 Fwd Earnings Yield N/A
FCF Yield -125,35%
Market Cap 72,50 M Enterprise Value -5,15 M
Per Share
EPS (Diluted TTM) -1,86 Revenue / Share N/A
FCF / Share -0,57 OCF / Share -0,57
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 64,48%
SBC-Adj. FCF -100,93 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -140,95 M -68,69 M
EPS (Diluted) -1,86 -1,62
Gross Profit 43 000,0 43 000,0
Operating Income -96,82 M -93,53 M
EBITDA — —
R&D Expenses 74,54 M 70,47 M
SG&A Expenses 22,28 M 23,10 M
D&A — —
Interest Expense — —
Income Tax 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 121,40 M 108,08 M
Total Liabilities 111,94 M 79,65 M
Shareholders' Equity 9,46 M 28,42 M
Total Debt — —
Cash & Equivalents 81,54 M 67,46 M
Current Assets 87,58 M 71,76 M
Current Liabilities 18,33 M 19,78 M